MANKIND PHARMA
Back to Income Statement
|
MANKIND PHARMA Last 5 Year Profit Before Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹2,398 Cr | ₹167,124 Cr | ₹1,975 Cr | ₹169 Cr | ₹14,377 Cr |
What is the latest Profit Before Tax of MANKIND PHARMA ?
| Year | Profit Before Tax |
|---|---|
| Mar2025 | ₹2,398 Cr |
| Mar2024 | ₹167,124 Cr |
| Mar2023 | ₹1,975 Cr |
| Mar2022 | ₹169 Cr |
| Mar2021 | ₹14,377 Cr |
How is Profit Before Tax of MANKIND PHARMA Trending?
| Years | Profit Before Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,398 Cr | -98.57 | |
| Mar2024 | ₹167,124 Cr | 8,363.68 | |
| Mar2023 | ₹1,975 Cr | 1,067.29 | |
| Mar2022 | ₹169 Cr | -98.82 | |
| Mar2021 | ₹14,377 Cr | - | |
Compare Profit Before Tax of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹85,197.8 Cr | -1.1% | -2.6% | -15.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,062.0 Cr | 0.4% | 2.6% | NA | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,192.0 Cr | -4.5% | 0.7% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,129.0 Cr | 5% | 4.1% | 37.2% | Stock Analytics | |
| CIPLA | ₹108,513.0 Cr | -0.5% | -3.4% | -6.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,250.0 Cr | 1.2% | 10.2% | 4.8% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -1.1% |
-2.6% |
-15.1% |
| SENSEX | -1% |
-0.1% |
7.9% |
You may also like the below Video Courses